Additionally, evidence has emerged indicating that IL-33 might influence breast cancer metabolism, especially by elevating Lipin-1 (LPIN-1) expression, a molecule involved in phospholipid metabolism [61,62]. The gene discussed is IL33; the disease is breast carcinoma.